Table of Contents

January 1, 2019; Volume 60,Issue 1

  1. Abdulghani, Mohammed

    1. Ventricular Tachycardia (VT) Substrate Characteristics: Insights from Multimodality Structural and Functional Imaging of the VT Substrate Using Cardiac MRI Scar, 123I-Metaiodobenzylguanidine SPECT Innervation, and Bipolar Voltage
      Hasan Imanli, Kiddy L. Ume, Jean Jeudy, Tamunoinemi Bob-Manuel, Mark F. Smith, Wengen Chen, Mohammed Abdulghani, Yousra Ghzally, Jagat Bandhu Mahat, Refael Itah, Alejandro Restrepo, Vincent Y. See, Stephen Shorofsky, Vasken Dilsizian and Timm Dickfeld
      Journal of Nuclear Medicine January 1, 2019, 60 (1) 79-85; DOI: https://doi.org/10.2967/jnumed.118.211698

  2. Ahmad, Rawaha

    1. Behavioral Symptoms in Premanifest Huntington Disease Correlate with Reduced Frontal CB1R Levels
      Jenny Ceccarini, Rawaha Ahmad, Laura Van de Vliet, Cindy Casteels, Mathieu Vandenbulcke, Wim Vandenberghe and Koen Van Laere
      Journal of Nuclear Medicine January 1, 2019, 60 (1) 115-121; DOI: https://doi.org/10.2967/jnumed.118.210393

  3. Allen, Darlene

    1. Abnormal Ventilation–Perfusion Scan Is Associated with Pulmonary Hypertension in Sickle Cell Adults
      Alem Mehari, Norris Igbineweka, Darlene Allen, Jim Nichols, Swee Lay Thein and Nargues A. Weir
      Journal of Nuclear Medicine January 1, 2019, 60 (1) 86-92; DOI: https://doi.org/10.2967/jnumed.118.211466

  4. Allmann, Jakob

    1. Modeling and Predicting Tumor Response in Radioligand Therapy
      Peter Kletting, Anne Thieme, Nina Eberhardt, Andreas Rinscheid, Calogero D’Alessandria, Jakob Allmann, Hans-Jürgen Wester, Robert Tauber, Ambros J. Beer, Gerhard Glatting and Matthias Eiber
      Journal of Nuclear Medicine January 1, 2019, 60 (1) 65-70; DOI: https://doi.org/10.2967/jnumed.118.210377

  5. Ametamey, Simon M.

    1. Diastereomerically Pure 6R- and 6S-3′-Aza-2′-18F-Fluoro-5-Methyltetrahydrofolates Show Unprecedentedly High Uptake in Folate Receptor–Positive KB Tumors
      Silvan D. Boss, Cristina Müller, Klaudia Siwowska, Raffaella M. Schmid, Viola Groehn, Roger Schibli and Simon M. Ametamey
      Journal of Nuclear Medicine January 1, 2019, 60 (1) 135-141; DOI: https://doi.org/10.2967/jnumed.118.213314

  6. An, Gwang Il

    1. Development of 64Cu-NOTA-Trastuzumab for HER2 Targeting: A Radiopharmaceutical with Improved Pharmacokinetics for Human Studies
      Sang-Keun Woo, Su Jin Jang, Min-Jung Seo, Ju Hui Park, Byoung Soo Kim, Eun Jung Kim, Yong Jin Lee, Tae Sup Lee, Gwang Il An, In Ho Song, Youngho Seo, Kwang Il Kim and Joo Hyun Kang
      Journal of Nuclear Medicine January 1, 2019, 60 (1) 26-33; DOI: https://doi.org/10.2967/jnumed.118.210294

  7. Avants, Brian

    1. Impact of Reference and Target Region Selection on Amyloid PET SUV Ratios in the Phase 1b PRIME Study of Aducanumab
      Ping Chiao, Barry J. Bedell, Brian Avants, Alex P. Zijdenbos, Marilyn Grand'Maison, Paul O’Neill, John O’Gorman, Tianle Chen and Robert Koeppe
      Journal of Nuclear Medicine January 1, 2019, 60 (1) 100-106; DOI: https://doi.org/10.2967/jnumed.118.209130

  8. Barnhart, Todd E.

    1. In Vivo Characterization and Quantification of Neurofibrillary Tau PET Radioligand 18F-MK-6240 in Humans from Alzheimer Disease Dementia to Young Controls
      Tobey J. Betthauser, Karly A. Cody, Matthew D. Zammit, Dhanabalan Murali, Alexander K. Converse, Todd E. Barnhart, Charles K. Stone, Howard A. Rowley, Sterling C. Johnson and Bradley T. Christian
      Journal of Nuclear Medicine January 1, 2019, 60 (1) 93-99; DOI: https://doi.org/10.2967/jnumed.118.209650

  9. Barth, Vanessa N.

    1. Evaluation of a PET Radioligand to Image O-GlcNAcase in Brain and Periphery of Rhesus Monkey and Knock-Out Mouse
      Soumen Paul, Mohammad B. Haskali, Jeih-San Liow, Sami S. Zoghbi, Vanessa N. Barth, Marcy Comly Kolodrubetz, Michelle R. Bond, Cheryl L. Morse, Robert L. Gladding, Michael P. Frankland, Nancy Kant, Lawrence Slieker, Sergey Shcherbinin, Hugh N. Nuthall, Paolo Zanotti-Fregonara, John A. Hanover, Cynthia Jesudason, Victor W. Pike and Robert B. Innis
      Journal of Nuclear Medicine January 1, 2019, 60 (1) 129-134; DOI: https://doi.org/10.2967/jnumed.118.213231

  10. Baum, Richard P.

    1. Caveat Emptor: Let Our Acclaim of the Apotheosis of PRRT Not Blind Us to the Error of Prometheus
      Lisa Bodei, Ken Herrmann, Richard P. Baum, Mark Kidd, Anna Malczewska and Irvin M. Modlin
      Journal of Nuclear Medicine January 1, 2019, 60 (1) 7-8; DOI: https://doi.org/10.2967/jnumed.118.219386
« Previous (Pages : 1 2 3 4 5 6 ... 20) Next »
Back to top

In this issue